Table 3.
Study | Years | Country | Assay | Population | Samples (n) | Prevalence in MSM as compared with controls | Odds ratio for HEV seropositivity in MSM (95% CI) |
---|---|---|---|---|---|---|---|
Payne et al. [15] | 2008 | UK | Wantai | HIV-negative men | 422 | 10·4% in MSM vs. 3·5% in heterosexuals | 3·1 |
Lanini et al. [14] | 2002–2011 | Italy | Dia. pro | Subjects that underwent HIV testing and counseling | 1116 | Not reported | 1·9 (1·03–3·5) |
Keane et al. [19] | 2009–2010 | UK | Wantai | HIV-infected subjects | 138 | Not reported | 0·36 (0·09–1·34) |
Pineda et al. [18] | 2009 | Spain | Wantai | HIV-infected subjects | 613 | Not reported | 1·55 (0·86–2·78) |
Present study | 2014–2016 | Belgium | Wantai | Subjects attending a STI clinic with a HIV test performed | 576 | 8·9% in MSM vs. 9·1% in heterosexuals | 0·98 (0·53–1·82) |